Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats.

@article{Xu2010ProtectiveEO,
  title={Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats.},
  author={Meng Xu and Lianghe Sheng and Xinhai Zhu and Shibin Zeng and Dexiang Chi and Guojun Zhang},
  journal={Tumori},
  year={2010},
  volume={96 3},
  pages={460-4}
}
AIMS AND BACKGROUND Doxorubicin (Dox) is effective in curative and adjuvant chemotherapy of malignant tumors. Cardiotoxicity is the chief toxic effect that limits the clinical use of Dox. We studied the effects of tetrandrine (Tet) on doxorubicin-induced cardiotoxicity in rats and its protective activity. MATERIALS AND METHODS Sprague-Dawley rats were randomly divided into the following 4 groups: a control group (received only saline), Dox group (received only Dox), Tet/Dox group (received… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis.

American journal of physiology. Heart and circulatory physiology • 2015
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Anthracycline cardiotoxicity: from bench to bedside.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2008

Lipsultz SE: Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management

E Barry, JA Alavarez, RE Scully, TL Miller
Expert Opin Pharmacother, • 2007

An experimental study of Tetrandrine for reversal of drug resistance and counteraction of apoptosis in lung cancer chemotherapy

M Xu, P Zhou
New JTrad ChinMed, • 2006

Similar Papers

Loading similar papers…